my account  log out
 

Magic™ TCR Repertoire Analysis for Minimal Residual Disease Quantification

Create: 03/26/2019
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:Creative Biolabs has applied our advanced Magic™ TCR repertoire analysis platform to MRD quantification for highly accurate and reproducible results. MRD is the name given to small numbers of leukemic cells or other cancer cells that remain in the patient during treatment or after treatment when the patient is in remission. It is the major cause of relapse in cancer and leukemia. https://www.creative-biolabs.com/tcr-repertoire-analysis-for-minimal-residual-disease-quantification.html
City:Shirley[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer271
Feb 01 2023 GVBE Buffer279
Feb 01 2023 GVB++ (with Ca and Mg) Buffer279
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)274
Aug 30 2019Anti-HSV-2 gH Antibody464
Aug 30 2019Anti-L. major LPG Antibody546
Aug 30 2019Anti-DENV-1 Antibody454
Aug 30 2019Anti-BPV-1 L1 Antibody468
Aug 30 2019Anti-H3N2 HA Antibody456
Aug 30 2019Anti-EIAV env Antibody477

return back

Copyright © toextrade Inc. All rights reserved. Contact us